Showing results (111-120 of 177) with videos related to
Sort By:
Pageof 18
Scientific Reports|February 26, 2021
A bladder cancer patient-derived xenograft displays aggressive growth dynamics in vivo and in organoid cultureElise Y Cai, Jose Garcia, Yuzhen Liu, et al.Prostate Cancer and Prostatic Diseases|March 21, 2019
Association of prostate cancer SLCO gene expression with Gleason grade and alterations following androgen deprivation therapyMazen Alsinnawi, Ailin Zhang, Daniella Bianchi-Frias, et al.Chest|March 15, 2014
A preliminary quality of life questionnaire-bronchiectasis: a patient-reported outcome measure for bronchiectasisAlexandra L Quittner, Kristen K Marciel, Matthias A Salathe, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 19, 2021
Circulating and Intratumoral Adrenal Androgens Correlate with Response to Abiraterone in Men with Castration-Resistant Prostate CancerElahe A Mostaghel, Brett T Marck, Orpheus Kolokythas, et al.Clinical Genitourinary Cancer|May 19, 2024
Adjuvant Chemotherapy and Survival After Radical Cystectomy in Histologic Subtype Bladder CancerElizabeth L Koehne, Dimitra R Bakaloudi, Fady Ghali, et al.Clinical Genitourinary Cancer|June 21, 2023
Metastatic Bladder Cancer Expression and Subcellular Localization of Nectin-4 and Trop-2 in Variant Histology: A Rapid Autopsy StudyFady Ghali, Funda Vakar-Lopez, Martine P Roudier, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 30, 2016
A Phase II Trial of Abiraterone Combined with Dutasteride for Men with Metastatic Castration-Resistant Prostate CancerRana R McKay, Lillian Werner, Elahe A Mostaghel, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 11, 2013
Targeted androgen pathway suppression in localized prostate cancer: a pilot studyElahe A Mostaghel, Peter S Nelson, Paul Lange, et al.Prostate Cancer and Prostatic Diseases|December 22, 2017
Post prostatectomy outcomes of patients with high-risk prostate cancer treated with neoadjuvant androgen blockadeRana R McKay, Bruce Montgomery, Wanling Xie, et al.European Urology|March 12, 2016
Low Incidence of Corticosteroid-associated Adverse Events on Long-term Exposure to Low-dose Prednisone Given with Abiraterone Acetate to Patients with Metastatic Castration-resistant Prostate CancerKarim Fizazi, Kim N Chi, Johann S de Bono, et al.Pageof 18